Medical Device and Diagnostic Industry (MD+DI)

Next-Gen Sequencing Is Going Global, And 2026 Could Be the Tipping Point

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
IEEE

sigRGCN: A Robust Residual Graph Convolutional Network for scRNA-Seq Data Clustering

Abstract: Clustering is a crucial step in single-cell RNA sequencing (scRNA-seq) data analysis, facilitating the discovery of new cell types and the grouping of similar cells. Recently, graph ...